Christof Rottenburger

Comparison of glucagon-like peptide-1 receptor (GLP-1R) PET/CT, SPECT/CT and 3T MRI for the localisation of occult insulinomas: evaluation of diagnostic accuracy in a prospective crossover imaging study

Kwadwo Antwi, Melpomeni Fani, Tobias Heye et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2018 · 126 citations

Positron Emission Tomography, Glucagon-like Peptide-1 Receptor, Medical Imaging +11

Localization of Hidden Insulinomas with ⁶⁸Ga-DOTA-Exendin-4 PET/CT: A Pilot Study

Kwadwo Antwi, Melpomeni Fani, Guillaume Nicolas et al. · Journal of Nuclear Medicine · 2015 · 124 citations · Full text

Dual-Biomarker Imaging of Regional Cerebral Amyloid Load and Neuronal Activity in Dementia with PET and ¹¹C-Labeled Pittsburgh Compound B

Philipp T. Meyer, Sabine Hellwig, Florian Amtage et al. · Journal of Nuclear Medicine · 2011 · 107 citations · Full text

Cholecystokinin 2 Receptor Agonist ¹⁷⁷Lu-PP-F11N for Radionuclide Therapy of Medullary Thyroid Carcinoma: Results of the Lumed Phase 0a Study

Christof Rottenburger, Guillaume Nicolas, Lisa McDougall et al. · Journal of Nuclear Medicine · 2019 · 87 citations · Full text

Targeting of the Cholecystokinin-2 Receptor with the Minigastrin Analog¹⁷⁷Lu-DOTA-PP-F11N: Does the Use of Protease Inhibitors Further Improve In Vivo Distribution?

Alexander Sauter, Rosalba Mansi, Ulrich Hassiepen et al. · Journal of Nuclear Medicine · 2018 · 58 citations · Full text